The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

BACKGROUND: The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), demonstrated its effectiveness for lowering serum phosphate levels, with low daily pill burden, in clinical trials of dialysis patients with hyperphosphatemia. This retrospective database analysis evaluated the real-w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Nephrol
Autori principali: Ramos, Rosa, Chazot, Charles, Ferreira, Anibal, Di Benedetto, Attilio, Gurevich, Konstantin, Feuersenger, Astrid, Wolf, Melanie, Arens, Hans-Jürgen, Walpen, Sebastian, Stuard, Stefano
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720479/
https://ncbi.nlm.nih.gov/pubmed/33287733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02188-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi